Jeanette Tseng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeanette Tseng has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Solomon Hsiang
Stanford Doerr School of Sustainability, Stanford University, Stanford, California, USA
4 shared publications - Emma Krasovich Southworth
Stanford University
3 shared publications - Kendon Bell
Global Policy Laboratory, Goldman School of Public Policy, UC Berkeley, Berkeley, USA
3 shared publications - Sébastien Annan-Phan
Global Policy Laboratory, Goldman School of Public Policy, UC Berkeley, Berkeley, USA
3 shared publications - Andrew Hultgren
Energy Policy Institute, University of Chicago, Chicago, USA
2 shared publications - Daniel Allen
Health Journalist
2 shared publications
Latest Publications
- Open Access
- 8 December 2021
- Published by Consortium of Universities for the Advancement of Hydrologic Science, Inc. (CUAHSI)
Standardized Nitrogen and Phosphorus Dataset (SNAPD)
- 8 December 2021
- Published by Consortium of Universities for the Advancement of Hydrologic Science, Inc. (CUAHSI)
Open AccessStandardized Nitrogen and Phosphorus Dataset (SNAPD)
- Top Cited PapersOpen Access
- 22 August 2020
- Published by Springer Nature in Nature
- Vol. 585 (7824) , E7
Publisher Correction: The effect of large-scale anti-contagion policies on the COVID-19 pandemic
- 22 August 2020
- Published by Springer Nature in Nature
- Vol. 585 (7824) , E7
Top Cited PapersOpen AccessPublisher Correction: The effect of large-scale anti-contagion policies on the COVID-19 pandemic
- Top Cited PapersOpen Access
- 8 June 2020
- Published by Springer Nature in Nature
- Vol. 584 (7820) , 262-267
The effect of large-scale anti-contagion policies on the COVID-19 pandemic
- 8 June 2020
- Published by Springer Nature in Nature
- Vol. 584 (7820) , 262-267
Top Cited PapersOpen AccessThe effect of large-scale anti-contagion policies on the COVID-19 pandemic
- Open Access
The Effect of Large-Scale Anti-Contagion Policies on the COVID-19 Pandemic
Governments around the world are responding to the novel coronavirus (COVID-19) pandemic 1 with unprecedented policies designed to slow the growth rate of infections. Many actions, such as closing schools and restricting populations to their homes, impose large and visible costs on society, but their benefits cannot be directly observed and are currently understood only through process-based simulations. 2–4 Here, we compile new data on 1,717 local, regional, and national non-pharmaceutical interventions deployed in the ongoing pandemic across localities in China, South Korea, Italy, Iran, France, and the United States (US). We then apply reduced-form econometric methods, commonly used to measure the effect of policies on economic growth, 5,6 to empirically evaluate the effect that these anti-contagion policies have had on the growth rate of infections. In the absence of policy actions, we estimate that early infections of COVID-19 exhibit exponential growth rates of roughly 38% per day. We find that anti-contagion policies have significantly and substantially slowed this growth. Some policies have different impacts on different populations, but we obtain consistent evidence that the policy packages now deployed are achieving large, beneficial, and measurable health outcomes. We estimate that across these six countries, interventions prevented or delayed on the order of 62 million confirmed cases, corresponding to averting roughly 530 million total infections. These findings may help inform whether or when these policies should be deployed, intensified, or lifted, and they can support decision-making in the other 180+ countries where COVID-19 has been reported. 7
Open AccessThe Effect of Large-Scale Anti-Contagion Policies on the COVID-19 Pandemic
Governments around the world are responding to the novel coronavirus (COVID-19) pandemic 1 with unprecedented policies designed to slow the growth rate of infections. Many actions, such as closing schools and restricting populations to their homes, impose large and visible costs on society, but their benefits cannot be directly observed and are currently understood only through process-based simulations. 2–4 Here, we compile new data on 1,717 local, regional, and national non-pharmaceutical interventions deployed in the ongoing pandemic across localities in China, South Korea, Italy, Iran, France, and the United States (US). We then apply reduced-form econometric methods, commonly used to measure the effect of policies on economic growth, 5,6 to empirically evaluate the effect that these anti-contagion policies have had on the growth rate of infections. In the absence of policy actions, we estimate that early infections of COVID-19 exhibit exponential growth rates of roughly 38% per day. We find that anti-contagion policies have significantly and substantially slowed this growth. Some policies have different impacts on different populations, but we obtain consistent evidence that the policy packages now deployed are achieving large, beneficial, and measurable health outcomes. We estimate that across these six countries, interventions prevented or delayed on the order of 62 million confirmed cases, corresponding to averting roughly 530 million total infections. These findings may help inform whether or when these policies should be deployed, intensified, or lifted, and they can support decision-making in the other 180+ countries where COVID-19 has been reported. 7